66621-0150Level 3
ANASCORP (centruroides (scorpion) immune F(ab)2 (equine))
**Product type:** Plasma Derivative
**Active ingredient:** CENTRUROIDES FAB2 ANTIVENIN (EQUINE)
**Strength:** 7 mg/mL
**Dosage form:** Injection, Powder, Lyophilized, For Solution
**Route:** Intravenous
**Labeler:** Rare Disease Therapeutics, Inc
**Marketing category:** BLA (BLA125335)
**Pharmacologic class:** Antivenin [EPC], Antivenins [CS], Passively Acquired Immunity [PE], Venom Neutralization [MoA]
GET
/api/v1/systems/ndc_fda/nodes/66621-0150Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.